TRECO DOUGLAS A sold 17.7% of their position (8.82K shares) of INOZYME PHARMA, INC. on the open market
Open‑market sale worth $7.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2025ACC: 0000950170-25-050443
-8.82K
Net shares
Net seller
$7.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 33.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
100.5%
4/1/2025
24.86K→49.87K
Common Stock
Direct
Shares
−8.82K
Price / share
$0.89
Trade value
$7.85K
% of position
17.7%
4/2/2025
49.87K→41.05K
Total
Net shares
+16.18K
Net value
-$7.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | M · Option Exercise | +25K | — | — | 100.5% | 24.86K | 49.87K |
| Common Stock Direct | 4/2/2025 | S · Sale | −8.82K | $0.89 | $7.85K | 17.7% | 49.87K | 41.05K |
| Total | +16.18K | -$7.85K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
Held after
50K
Exercisable
—
4/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock25K shares | 4/1/2025 | M · Option Exercise | −25K | — | 50K |